150 mg
Trade Name
Lacosamide Genepharm
Film coated oblong biconvex tablets
Request Type
New Registration
Drug Type
Generic(Multisource) Drug
Approval Date
SFDA Approved Use
Lacosamide is indicated as monotherapy in the treatment of partial- seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epi-lepsy.
Lacosamide is indicated as adjunctive therapy
• in the treatment of partial- seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
• in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.
Lacosamide is indicated as adjunctive therapy
• in the treatment of partial- seizures with or without secondary generalisation in adults, adolescents and children from 4 years of age with epilepsy.
• in the treatment of primary generalised tonic-clonic seizures in adults, adolescents and children from 4 years of age with idiopathic generalised epilepsy.